Fluvoxamine CR in the long-term treatment of social anxiety disorder: The 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial

Dan J. Stein, Herman G.M. Westenberg, Haichen Yang, David Li, Luigi M. Barbato

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Fluvoxamine CR in the long-term treatment of social anxiety disorder: The 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences